Publication:
The circadian timing system as a toxicity target of the anticancer mTOR inhibitor everolimus in mice.

dc.contributor.authorOZTURK, N.
dc.contributor.authorÖZTÜRK, DİLEK
dc.contributor.authorÖZTÜRK CİVELEK, DİLEK
dc.contributor.authorKaptan, Engin
dc.contributor.authorSancar Baş, Serap
dc.contributor.authorÇınar, Suzan
dc.contributor.authorGiachetti, Sylvie
dc.contributor.authorLi, Xiao Mei
dc.contributor.authorLevi, Francis
dc.contributor.authorOKYAR, ALPER
dc.date.accessioned2019-10-05T21:36:43Z
dc.date.available2019-10-05T21:36:43Z
dc.date.issued2016-06-30
dc.identifier.urihttps://hdl.handle.net/20.500.12645/7753
dc.language.isoen
dc.subjectOZTURK N., ÖZTÜRK D., PALA-KARA Z., Kaptan E., Sancar Baş S., Çınar S., Deniz G., Li X. M. , Giachetti S., Levi F., et al., -The circadian timing system as a toxicity target of the anticancer mTOR inhibitor everolimus in mice.-, 7. European Congress of Pharmacology, İstanbul, Türkiye, 26 June 2016, ss.30
dc.titleThe circadian timing system as a toxicity target of the anticancer mTOR inhibitor everolimus in mice.
dc.typeConference Paper
dspace.entity.typePublication
dspace.relatedentity.typePerson
local.avesis.idc079b0ed-9a06-4952-a44e-5cd57724f574
local.avesis.response7629
person.identifier.orcid0000-0003-2485-891X
relation.isAuthorOfPublication821c461c-752b-4a78-a2e5-a6aaf5076b88
relation.isAuthorOfPublication.latestForDiscovery821c461c-752b-4a78-a2e5-a6aaf5076b88

Files